Code | 2361E | ||||||||||
MA number | 59/0285/22-S | ||||||||||
Product Form: | cps end 14x120 mg (blis.Al//PVC/PVDC - kalend.bal.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister Al/PVC/PVDC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Dimtruzic_11_2022.pdf |
SPC: | SPC_Dimtruzic 120 mg_240 mg_02.2023.pdf |
Safety feature | Unknown |
Data update: | 03.02.2023 |